š Aster DM Share Price: A Dividend Opportunity for Investors š°
Good news for investors looking to earn money by investing in dividend-paying companies! Aster DM Healthcare company may provide its eligible shareholders with a dividend of 70 to 80 percent of the face value. The company has not paid dividends to its shareholders for the past five years. However, after the news of dividend distribution came out, there has been an increase in the share price of Aster DM Healthcare company.
In yesterday’s trading session, Aster DM Healthcare shares were trading at Rs. 449.75, showing a 12 percent increase. Today, the stock is still being bought in large quantities. Currently, on Wednesday, January 17, 2024, Aster DM Healthcare stock is trading at Rs. 434.30, showing a 2.15% increase. On Thursday (January 18, 2024), the shares were trading at Rs. 438, showing a 0.13% increase.
On Monday, Aster DM Healthcare informed the Securities and Exchange Board of India (SEBI) that it is in talks with Alpha GCC to sell its stake in FJGCC. The company has informed SEBI that discussions on this matter have been conducted satisfactorily. On November 28, 2023, Aster DM Healthcare announced that the entire deal could be completed for $1.01 billion. Out of this, $90.3 million will be received upon completion of the transaction, while the remaining $98.8 million will be paid in installments.
Once this pending transaction is completed, Aster DM Healthcare can distribute dividends to its investors. In Tuesday’s trading session, Aster DM Healthcare shares were trading 12% higher. The shares were trading at Rs. 440 on the BSE index.
In the past year, Aster DM Healthcare shares have given a 97% return to its investors. The establishment of Aster DM Healthcare company took place in Dubai in 1987. Currently, the company manages 33 hospitals, 127 pharmacies, 527 medical centers, and 220 laboratories.
š Don’t miss out on this opportunity to invest in Aster DM Healthcare shares and potentially earn a dividend! šš°
Disclaimer: This is News Coverage with Opinions of Experts and Should Not Be Taken as Direct Market Buying Tip. Market is always subject to risk. We recommend taking our content as research before investing.
